KDIGO Controversies Conference on the Management of Patients with Diabetes and Chronic Kidney Disease February 5-8, 2015 Vancouver, Canada --- CONFERENCE AGENDA --- 1 Thursday, February 5 19:00 – 21:00 hrs 19:00 hrs Welcome Reception & Informal Cocktails Location: Vistas 360 ------------------------------------------------------------------------------------------------------------ Friday, February 6 08:30 – 18:00 hrs 06:30 – 08:30 hrs Continental Breakfast Available Location: P2B Bistro Introduction: Meeting Overview Location: Salon A 08:30 – 08:45 hrs Welcome & Introductions Presenters: John Davis, KDIGO CEO David Wheeler & Bert KasisKe, KDIGO Co-Chairs 08:45 – 09:15 hrs Conference Overview & Objectives Presenters: Per-HenriK Groop & Vlado PerKovic, Conference Co-Chairs 09:15 – 09:30 hrs Epidemiology of DKD Presenter: Per-HenriK Groop Plenary Session #1 09:30 – 09:45 hrs What Can Be Achieved with Glycemic Control? Presenter: Michel Marre 09:45 – 10:00 hrs Balancing Risk and Benefit in Chronic Kidney Disease Presenter: Merlin Thomas 10:00 – 10:15 hrs Safety of New Agents Presenter: Steven Kahn 10:15 – 11:00 hrs Q&A 2 11:00 – 11:15 hrs Break Location: Foyer Plenary Session #2 11:15 – 11:45 hrs Novel Treatments in DKD Presenter: Rajiv Agarwal 11:45 – 12:15 hrs Experimental Agents in DKD Presenter: Robyn Langham 12:15 – 13:00 hrs Q&A 13:00 – 14:00 hrs Lunch Location: Salon F Plenary Session #3 14:00 – 14:15 hrs Role of Antiplatelets in DKD Presenter: Meg Jardine 14:15 – 14:30 hrs Role of Novel Anticoagulants in DKD Presenter: Vlado PerKovic 14:30 – 15:00 hrs Dyslipidemia in DKD: Current & Future Lipid-Lowering Strategies Presenter: Christoph Wanner 15:00 – 15:45 hrs Q&A 15:45 – 16:00 hrs Break Location: Foyer Plenary Session #4 16:00 – 16:15 hrs Lifestyle & Dietary Interventions in DKD Presenter: Meg Jardine 16:15 – 16:30 hrs Is Lower the BP Target the Better in DKD? Presenter: George Bakris 3 16:30 – 16:45 hrs Is Dual Blockade in DKD Dead? Presenter: MarK Cooper 16:45 – 17:00 hrs Role of Mineralocorticoid Receptor Antagonists in DKD Presenter: Peter Rossing 17:00 – 17:45 hrs Q&A 17:45 – 18:00 hrs Closing Remarks Presenter: Vlado PerKovic 18:00 hrs Adjourn (evening on own) ----------------------------------------------------------------------------------------------------------- Saturday, February 7 08:30 to 18:15 hrs 06:30 – 08:30 hrs Continental Breakfast Available Location: P2B Bistro Plenary Session #5 08:30 – 08:45 hrs Improving Future Clinical Trial Designs Presenter: Dick de Zeeuw 08:45 – 09:00 hrs Moving from Efficacy to Effectiveness Presenter: Brenda Hemmelgarn 09:00 – 09:45 hrs Q&A 09:45 – 10:00 hrs Breakout Session Remit Presenters: Per-HenriK Groop & Vlado PerKovic 10:00 – 12:30 hrs Breakout Session 1 Breakout Group #1: Safety of Treatments in Diabetes and Kidney Disease Discussion Leaders: Brenda Hemmelgarn & Merlin Thomas Location: Salon E 4 Breakout Group #2: Efficacy of Glycemic Control Discussion Leaders: MarK Cooper & Steven Kahn Location: Salon D Breakout Group #3: Therapies for Protecting Kidney Function Discussion Leaders: Rajiv Agarwal & Paola Fioretto Location: Salon A Breakout Group #4: Therapeutic Effects on Cardiovascular Risk & Other Outcomes Discussion Leaders: Adeera Levin & Christoph Wanner Location: Salon C 12:30 – 13:30 hrs Lunch Location: Salon F Breakout Group Preliminary Reports and Discussion Location: Salon A 13:30 – 14:00 hrs Breakout Group #1: Safety of Treatments in Diabetes and Kidney Disease Discussion Leaders: Brenda Hemmelgarn & Merlin Thomas 14:00 – 14:30 hrs Breakout Group #2: Efficacy of Glycemic Control Discussion Leaders: MarK Cooper & Steven Kahn 14:30 – 15:00 hrs Breakout Group #3: Therapies for Protecting Kidney Function Discussion Leaders: Rajiv Agarwal & Paola Fioretto 15:00 – 15:30 hrs Breakout Group #4: Therapeutic Effects on Cardiovascular Risk & Other Outcomes Discussion Leaders: Adeera Levin & Christoph Wanner 15:30 – 15:45 hrs Break Location: Foyer 15:45 – 18:15 hrs Breakout Session 2 Breakout Group #1: Safety of Treatments in Diabetes and Kidney Disease Discussion Leaders: Brenda Hemmelgarn & Merlin Thomas Location: Salon E 5 Breakout Group #2: Efficacy of Glycemic Control Discussion Leaders: MarK Cooper & Steven Kahn Location: Salon D Breakout Group #3: Therapies for Protecting Kidney Function Discussion Leaders: Rajiv Agarwal & Paola Fioretto Location: Salon A Breakout Group #4: Therapeutic Effects on Cardiovascular Risk & Other Outcomes Discussion Leaders: Adeera Levin & Christoph Wanner Location: Salon C 19:00 hrs Group Dinner Location: BlacK & Blue Restaurant (Meet in hotel lobby at 19:00 hrs to walK to restaurant) ------------------------------------------------------------------------------------------------------------ Sunday, February 8 08:30 to 12:00 hrs 06:30 – 08:30 hrs Continental Breakfast Available Location: P2B Bistro Breakout Group Final Reports and Discussion Location: Salon A 08:30 – 09:15 hrs Breakout Group #1: Safety of Treatments in Diabetes and Kidney Disease Discussion Leaders: Brenda Hemmelgarn & Merlin Thomas 09:15 – 10:00 hrs Breakout Group #2: Efficacy of Glycemic Control Discussion Leaders: MarK Cooper & Steven Kahn 10:00 – 10:45 hrs Breakout Group #3: Therapies for Protecting Kidney Function Discussion Leaders: Rajiv Agarwal & Paola Fioretto 6 10:45 – 11:30 hrs Breakout Group #4: Therapeutic Effects on Cardiovascular Risk & Other Outcomes Discussion Leaders: Adeera Levin & Christoph Wanner 11:30 – 12:00 hrs Conference summation and next steps 7 .